Atea Pharmaceuticals
Boston
About Atea Pharmaceuticals
Atea Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections. It caters to the healthcare industry and engages in the discovery and development of antiviral therapeutics that enable patients to have treatment for infections caused by RNA and DNA viruses. Atea Pharmaceuticals was established in 2014 and is headquartered in Boston, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Total funding: $283.4M
- Funding stage: IPO
- Last round: Series D (May 2020)
- Ticker: nasdaq:AVIR
- Website: ateapharma.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/atea-pharmaceuticals-218210 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.